Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria
Cosson V, Fu R, Kulasekararaj A, Nishimura J-I, Panse J, Röth A, Scheinberg P, Tong H, Yoon S-S, Beveridge L, Gotanda K, Jaminion F, Henrich A, Lundberg P, Shi D, Sreckovic S, Zhang Y, Zhang Z, Benkali K, Buatois S